Thomas Meier
Oprichter bij SANTHERA PHARMACEUTICALS HOLDING AG
Vermogen: 141 664 $ op 30-04-2024
Actieve functies van Thomas Meier
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SANTHERA PHARMACEUTICALS HOLDING AG | Voorzitter | 30-06-2022 | - |
Oprichter | 07-09-2004 | - | |
Directeur/Bestuurslid | 04-04-2017 | 30-06-2022 | |
Algemeen Directeur | 11-10-2011 | 01-12-2019 | |
Investor Relations Contact | - | - | |
Public Communications Contact | - | - | |
ONCONETIX, INC. | Directeur/Bestuurslid | 06-02-2024 | - |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Directeur/Bestuurslid | 01-05-2020 | - |
Viopas Venture Consulting GmbH
Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Corporate Officer/Principal | - | - |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Directeur/Bestuurslid | 01-01-2022 | - |
Loopbaan van Thomas Meier
Eerdere bekende functies van Thomas Meier
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PharmaBiome AG
PharmaBiome AG Miscellaneous Commercial ServicesCommercial Services PharmaBiome AG specializes in isolation, characterization, and technology of novel intestinal microbes. It develops and produces microbiome therapies to treat intestinal diseases. The company was founded by Tomas de Wouters and is headquartered in Zurich, Switzerland. | Voorzitter | 01-07-2020 | 01-01-2021 |
MyoContract AG | Algemeen Directeur | 01-01-2000 | 01-01-2004 |
Oprichter | 01-01-2000 | 01-01-2004 |
Opleiding van Thomas Meier
University of Basel | Doctorate Degree |
Statistieken
Internationaal
Zwitserland | 7 |
Verenigde Staten | 3 |
Operationeel
Director/Board Member | 4 |
Chairman | 3 |
Founder | 3 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
ONCONETIX, INC. | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
MyoContract AG | Health Technology |
Novaremed AG
Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel. | Health Technology |
PharmaBiome AG
PharmaBiome AG Miscellaneous Commercial ServicesCommercial Services PharmaBiome AG specializes in isolation, characterization, and technology of novel intestinal microbes. It develops and produces microbiome therapies to treat intestinal diseases. The company was founded by Tomas de Wouters and is headquartered in Zurich, Switzerland. | Commercial Services |
Viopas Venture Consulting GmbH
Viopas Venture Consulting GmbH Investment ManagersFinance Viopas Venture Consulting GmbH (Viopas Venture Consulting) is a venture capital firm founded in 2016 by Simon Jules Nebel. The firm is headquartered in Zürich, Switzerland. | Finance |
Visgenx, Inc.
Visgenx, Inc. BiotechnologyHealth Technology Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Thomas Meier
- Ervaring